Ruben Mesa, MD
Mayo Clinic
2
1
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
John Mascarenhas, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Ronald Hoffman, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Bik To, MD
Royal Adelaide Hospital
Shared therapeutic areas:
Worked with same sponsors:
John Seymour, M.D.
Peter MacCallum Cancer Centre, Australia
Shared therapeutic areas:
Worked with same sponsors:
Rami Komrokji, MD
H. Lee Moffitt Cancer Center and Research Institute
Shared therapeutic areas:
Worked with same sponsors:
Martha Wadleigh, MD
Dana-Farber Cancer Institute
Shared therapeutic areas:
Worked with same sponsors:
Andrew Roberts, M.D.
Melbourne Health
Shared therapeutic areas:
Worked with same sponsors:
Jean-Jacques Kiladjian, MD
Hopitaux de Paris
Shared therapeutic areas:
Worked with same sponsors:
Mary Frances McMullin, MD
Belfast Health and Social Care Trust
Shared therapeutic areas:
Worked with same sponsors:
Claire Harrison, MD
Guy's and St Thomas' NHS Foundation Trust
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
All 2 trials loaded